Torthaí cuardaigh - Kang-shuai Li

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Íomhá chlúdaigh

    Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma de réir Kang-shuai Li, Yi Liu, Tie-zhong Zhang, Yun-fei Xu, Zong-li Zhang

    Foilsithe / Cruthaithe 2024
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Íomhá chlúdaigh

    Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC de réir Li-xin Du, Guo-li Sheng, An-da Shi, Kang-shuai Li, Zeng-li Liu, Yong-chang Tang, Yi Liu, Zong-li Zhang

    Foilsithe / Cruthaithe 2024
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: